良性前列腺增生的临床进展性
张祥华 张祥华，北京大学第一医院泌尿外科 北京大学泌尿外科研究所，100034
摘要: 良性前列腺增生(benign prostatic hyperplasia，BPH)是一种组织学诊断，临床BPH通常表现为解剖学或影像学证实的前列腺增大(benign prostatic enlargement，BPE)，患者主观症状为主的下尿路症状(lower urinary tract symptoms，LUTS)，以及尿动力学反映的膀胱出口梗阻(bladder outlet obstruction，BOO)。目前的研究已经证实BPH是一种缓慢进展的良性疾病。在其缓慢的临床进展过程中，BPH患者主要表现为逐渐加重的下尿路症状，..
HTML
PDF文献标引:张祥华.良性前列腺增生的临床进展性.中华临床医师杂志（电子版）,2007,1(7):521-523.
参考文献
[1] McConnell JD，Roehrborn CG，Bautista OM，et al.The long-term effect of doxazosin，finasteride，and combination therapy on the clinical progression of benign prostatic hyperplasia.N Engl J Med,2003,349(25)：2387－2398.[PubMed][2] Jacobsen SJ，Jacobson DJ，Girman CJ，et al.Treatment for benign prostatic hyperplasia among community dwelling men：the Olmsted County study of urinary symptoms and health status.J Urol,1999,162(4)：1301－1306.[PubMed]
[3] McConnell JD， Bruskewitz R， Walsh P， et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia.Finasteride Long-Term Efficacy and Safety Study Group.N Engl J Med,1998,338(9)：557－563.[PubMed]
[4] Lepor H，Williford WO，Barry MJ，et al.The efficacy of terazosin，finasteride，or both in benign prostatic hyperplasia.Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.N Engl J Med,1996,335(8)：533－539.[PubMed]
[5] Djavan B，Nickel JC，de la Rosette J，et al.The urologist view of BPH progression：results of an international survey.Eur Urol,2002,41(5)：490－496.[PubMed]
[6] Boyle P，Robertson C，Mazzetta C，et al.The relationship between lower urinary tract symptoms and health status： the UREPIK study.BJU Int,2003,92(6)：575－580.[PubMed]
[7] Kim CI，Chang HS，Kim BK，et al.Long-term results of medical treatment in benign prostatic hyperplasia.Urology,2006,68(5)：1015－1019.
[8] 张祥华，王行环，王刚，等.良性前列腺增生诊断治疗指南.见：那彦群，主编.中国泌尿外科疾病诊断治疗指南.北京：人民卫生出版社，2007.167－204.
[9] Emberton M，Zinner N， Michel MC，et al.Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia：therapeutic options for the man at risk.BJU Int,2007,100(2)：249－253.[PubMed]
